Fifteen-Year Biochemical Relapse-Free Survival, Cause-Specific Survival, and Overall Survival Following I125 Prostate Brachytherapy in Clinically Localized Prostate Cancer: Seattle Experience
- 1 October 2011
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 81 (2), 376-381
- https://doi.org/10.1016/j.ijrobp.2010.05.042
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Trends in Gleason Score: Concordance Between Biopsy and Prostatectomy over 15 YearsUrology, 2008
- Permanent prostate brachytherapy preplannned technique: The modern Seattle method step by step and dosimetric outcomesBrachytherapy, 2008
- Contemporary Evaluation of the D’Amico Risk Classification of Prostate CancerUrology, 2007
- Prostate brachytherapy postimplant dosimetry: A comparison of suture-embedded and loose seed implantsBrachytherapy, 2006
- Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 yearsCancer, 2002
- PREDICTING PROSTATE SPECIFIC ANTIGEN OUTCOME PREOPERATIVELY IN THE PROSTATE SPECIFIC ANTIGEN ERAJournal of Urology, 2001
- HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCERJournal of Urology, 2001
- ERA SPECIFIC BIOCHEMICAL RECURRENCE-FREE SURVIVAL FOLLOWING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCERJournal of Urology, 2001
- Gleason Score 2–4 Adenocarcinoma of the Prostate on Needle BiopsyThe American Journal of Surgical Pathology, 2000
- A Dose–Response Study for I-125 Prostate ImplantsInternational Journal of Radiation Oncology*Biology*Physics, 1998